Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDRH Ombudsman Appointed From FDA's Public Affairs Office

This article was originally published in The Gray Sheet

Executive Summary

The Center for Devices and Radiological Health's newly appointed Ombudsman and Quality Assurance Manager Les Weinstein will be responsible for revising the first draft of the device center's dispute resolution guidance, according to center Director David Feigal.

You may also be interested in...



People In Brief

CDRH needs new ombudsman: Les Weinstein served his last day as ombudsman for FDA's device center April 9 and now moves to the same post within FDA's new Center for Tobacco Products. Weinstein was appointed as CDRH's first ombudsman in 2000 to handle complaints from outside the agency and disputes between the center and companies. CDRH has yet to name a replacement (1"The Gray Sheet" March 20, 2000). Weinstein released his final annual report for the device center April 7

People In Brief

CDRH needs new ombudsman: Les Weinstein served his last day as ombudsman for FDA's device center April 9 and now moves to the same post within FDA's new Center for Tobacco Products. Weinstein was appointed as CDRH's first ombudsman in 2000 to handle complaints from outside the agency and disputes between the center and companies. CDRH has yet to name a replacement (1"The Gray Sheet" March 20, 2000). Weinstein released his final annual report for the device center April 7

ODE division directors

Dan Schulz, MD, acting director of the Division of Reproductive, Abdominal & Radiological Devices in FDA's Center for Devices and Radiological Health's Office of Device Evaluation since December 1998, is named permanent director Feb. 29. Jim Dillard, deputy director of the Division of Cardiovascular and Respiratory Devices since 1996, becomes director on March 12. Both directors will report to ODE Deputy Director Kimber Richter, MD

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013103

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel